CERUS INTERCEPT-Blood Products
Awarded Limited / Sole Source Justification Posted
See the award notice from .
- Solicitation number
- N6809620RC23017
- Agency
-
Naval Supply Systems Command
Department of the Navy, Department of Defense
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- N6264520P0024 Federal contract award
- Awardee
- Cerus Corporation
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
Notice details come from SAM.gov. Updated .
About this opportunity
This Limited/Sole Source Justification Notice from the Department of the Navy Naval Supply Systems Command awards an initial base contract to CERUS Corporation, with four option years, to supply annual shipments of platelet processing sets for two CERUS INTERCEPT illuminator systems installed at the United States Naval Hospital in Guam. Market research demonstrated CERUS as the only authorized source for the platelet sets compatible with the proprietary pathogen reduction technology, and for maintenance of the illuminators. The initial award provides for the base year quantity of platelet sets, shipping, and two technical service visits, with option years for annual platelet set quantities and maintenance through 2024.
Notice text
See attached Redacted J&A.
Awarded contract N6264520P0024 to unknown vendor for unknown amount on 2020-05-13.
Files
| File | Type | Posted |
|---|---|---|
| N6809620RC23017-Blood Bank-CERUS-GU-Attachment V-JA_FINAL_Redacted.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| CERUS INTERCEPT-Blood Products | Award Notice | |
| This notice | Limited / Sole Source Justification | |
| CERUS INTERCEPT-Blood Products | Solicitation | |
| CERUS INTERCEPT-Blood Products | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity